Bank of Montreal’s Passage Bio PASG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,456
Closed -$70.2K 4079
2022
Q4
$70.2K Buy
+2,456
New +$62K ﹤0.01% 3455
2022
Q3
Sell
-2,891
Closed -$140 4339
2022
Q2
$140 Sell
2,891
-299
-9% -$14K ﹤0.01% 3378
2022
Q1
$206K Buy
+3,190
New +$263K ﹤0.01% 3439
2021
Q2
Sell
-437
Closed -$149K 4585
2021
Q1
$149K Sell
437
-150
-26% -$64K ﹤0.01% 3230
2020
Q4
$311K Buy
587
+163
+38% +$65.3K ﹤0.01% 2974
2020
Q3
$124K Buy
424
+370
+685% +$127K ﹤0.01% 2974
2020
Q2
$26K Buy
+54
New +$24.3K ﹤0.01% 3733

Other funds holding PASG

Bank of Montreal's PASG Position: Q1 2023 in Review

Bank of Montreal sold out of Passage Bio (PASG) in Q1 2023, closing a stake of 2,456 shares — an estimated $70.2K sold.

Bank of Montreal first reported a position in PASG in Q2 2020 and held it in 7 quarters. The position peaked at $311K in Q4 2020. 58 funds tracked by Wall St. Rank hold PASG as of Q1 2023.

  • Bank of Montreal reported no remaining Passage Bio position as of Q1 2023 after selling out during the quarter.
  • Bank of Montreal sold 2,456 Passage Bio shares in Q1 2023, an estimated $70.2K.
  • Bank of Montreal first reported a position in Passage Bio in Q2 2020 and held it in 7 quarters.
  • Bank of Montreal's Passage Bio position peaked at $311K in Q4 2020.
  • 58 funds tracked by Wall St. Rank held Passage Bio as of Q1 2023.

Based on Bank of Montreal's 13F filing for Q1 2023, filed 13 Jun 2024.